Haemonetics 4th Quarter and Fiscal Year 2017 Earnings Release and Fiscal Year 2018 Guidance Available on Investor Relations Website

Go back to Haemonetics 4th Quarter and Fiscal Year 2017 Earnings Release and Fiscal Year 2018 Guidance Available on Investor Relations Website

Haemonetics (HAE) Tops Q4 EPS by 1c

May 8, 2017 6:11 AM EDT

Haemonetics (NYSE: HAE) reported Q4 EPS of $0.39, $0.01 better than the analyst estimate of $0.38. Revenue for the quarter came in at $228.1 million versus the consensus estimate of $219.42 million.

GUIDANCE:

Haemonetics sees FY2018 EPS of $1.55-$1.65, versus the consensus of $1.59.

For earnings history and earnings-related data on Haemonetics (HAE) click here.

... More